EXOSOMICS

EXOSOMICS

Pre-clinical
Siena, ItalyFounded 2011exosomics.eu

Rivela Diagnostics envisions a world in which a simple blood test is sufficient to allow Multi Cancer Early Detection, discovering cancer at the earliest detectable moment, enabling enhanced, personalised patient treatments and outcomes. By achieving this goal, we will reduce the devastating impact of the rise of global cancer rates and improve the lives of those affected by the disease.

Founded
2011
Focus
Diagnostics

About

Rivela Diagnostics envisions a world in which a simple blood test is sufficient to allow Multi Cancer Early Detection, discovering cancer at the earliest detectable moment, enabling enhanced, personalised patient treatments and outcomes. By achieving this goal, we will reduce the devastating impact of the rise of global cancer rates and improve the lives of those affected by the disease.

Funding History

2

Total raised: $15.2M

Series A$12MClaris VenturesJul 15, 2021
Seed$3.2MPanakes PartnersNov 15, 2019

Company Info

TypePrivate
Founded2011
LocationSiena, Italy
StagePre-clinical
SIMILAR COMPANIES
AAVantgarde Bio
AAVantgarde Bio
Pre-clinical · Milan
AB ANALITICA
AB ANALITICA
Pre-clinical · Padua
BetaGlue Therapeutics
BetaGlue Therapeutics
Phase 1 · Milan
Adienne Pharma and Biotech
Adienne Pharma and Biotech
Pre-clinical · Milan
Advaxia Biologics
Advaxia Biologics
Pre-clinical · Milan
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile